SEC Comment Letter to Traws Pharma, Inc. (TRAW) (CIK 0001130598) (TRAW)
Traws Pharma, Inc. (TRAW) (CIK 0001130598)
Date: July 7, 2026 · CIK: 0001130598 · Accession: 0000000000-26-006689
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-297195
Letter
Re: Traws Pharma, Inc. Registration Statement on Form S-3 Filed July 1, 2026 File No. 333-297195 Dear Iain Dukes: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Dickerson at 202-551-8013 with any questions.
July 7, 2026
Iain Dukes Chief Executive Officer Traws Pharma, Inc. 12 Penns Trail Newtown, PA 18940
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Bardia Moayedi, Esq.
Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
July 7, 2026
Iain Dukes
Chief Executive Officer
Traws Pharma, Inc.
12 Penns Trail
Newtown, PA 18940
Re: Traws Pharma, Inc.
Registration Statement on Form S-3
Filed July 1, 2026
File No. 333-297195
Dear Iain Dukes:
This is to advise you that we have not reviewed and will not review your
registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you that
the company and its management are responsible for the accuracy and adequacy of
their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.
Please contact Jessica Dickerson at 202-551-8013 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Bardia Moayedi, Esq.
</TEXT>
</DOCUMENT>